Suppression of the drug-induced morphine withdrawal syndrome by cyproheptadine.
D000818:Animals; D001835:Body Weight; D003533:Cyproheptadine / Q000627:therapeutic use*; D004361:Drug Tolerance; D005277:Fenfluramine / Q000494:pharmacology; D006801:Humans; D007031:Hypothalamus / Q000503:physiopathology; D007977:Levallorphan; D008297:Male; D009021:Morphine Dependence; D051381:Rats; D013375:Substance Withdrawal Syndrome / Q000188:drug therapy*
D005277:Fenfluramine; D003533:Cyproheptadine; D007977:Levallorphan